4.3 Article

Corporate Coalitions and Policy Making in the European Union: How and Why British American Tobacco Promoted Better Regulation

Journal

JOURNAL OF HEALTH POLITICS POLICY AND LAW
Volume 40, Issue 2, Pages 325-372

Publisher

DUKE UNIV PRESS
DOI: 10.1215/03616878-2882231

Keywords

public health policy; regulatory reform; European Union; ideational theory; think tanks

Funding

  1. Cancer Research UK (CR-UK)
  2. National Cancer Institute of the US National Institutes of Health [R01CA160695]
  3. Cancer Research UK [C27260/A8861]
  4. Economic and Social Research Council [ES/K001728/1]
  5. Economic and Social Research Council [ES/G007489/1, ES/K001728/1] Funding Source: researchfish
  6. Medical Research Council [MR/K023195/1, MR/K023195/1B, MC_UU_12017/6] Funding Source: researchfish
  7. ESRC [ES/K001728/1] Funding Source: UKRI
  8. MRC [MC_UU_12017/6, MC_U130085862] Funding Source: UKRI

Ask authors/readers for more resources

Over the past fifteen years, an interconnected set of regulatory reforms, known as Better Regulation, has been adopted across Europe, marking a significant shift in the way that European Union policies are developed. There has been little exploration of the origins of these reforms, which include mandatory ex ante impact assessment. Drawing on documentary and interview data, this article discusses how and why large corporations, notably British American Tobacco (BAT), worked to influence and promote these reforms. Our analysis highlights (1) how policy entrepreneurs with sufficient resources (such as large corporations) can shape the membership and direction of advocacy coalitions; (2) the extent to which think tanks may be prepared to lobby on behalf of commercial clients; and (3) why regulated industries (including tobacco) may favor the use of evidence tools, such as impact assessments, in policy making. We argue that a key aspect of BAT's ability to shape regulatory reform involved the deliberate construction of a vaguely defined idea that could be strategically adapted to appeal to diverse constituencies. We discuss the theoretical implications of this finding for the Advocacy Coalition Framework, as well as the practical implications, of the findings for efforts to promote transparency and public health in the European Union.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available